Lauren E. Haydu, PhD MPH

Cited by

	All	Since 2019
Citations	78933	47803
h-index	68	59
i10-index	150	141

10000

5000

2500

7500

200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024499 1038 1188 1190 1423 1468 1403 1415 1351 1345 1424 1707 1838 1973 2199 2515 2787 3536 5495 7707 8994 9352 8694 7505

Public access

View all

91 articles

6 articles*

available

not available

Based on funding mandates

Co-authors

John F ThompsonMelanoma Institute AustraliaVerified email at melanoma.org.au
Richard A ScolyerMelanoma Institute Australia, The University of Sydney, Royal Prince Alfred HospitalVerified email at sswahs.nsw.gov.au
Georgina V LongMelanoma Institute Australia, The University of Sydney and Royal North Shore HospitalVerified email at sydney.edu.au
Alexander M MenziesMelanoma Institute Australia, The University of Sydney, Royal North Shore HospitalVerified email at sydney.edu.au
Richard KeffordMacquarie UniversityVerified email at mq.edu.au
Robyn SawMelanoma Institute AustraliaVerified email at melanoma.org.au
A SpillaneUniversity of SydneyVerified email at melanoma.org.au
Jonathan StretchMelanoma Institute AustraliaVerified email at melanoma.org.au
Jeff GershenwaldThe University of Texas MD Anderson Cancer CenterVerified email at mdanderson.org
Graham MannCollege of Health and Medicine, Australian National UniversityVerified email at anu.edu.au
Gerald FogartyICON Cancer Centre, Revesby, Sydney NSW.Verified email at Icon.Team
James S WilmottMelanoma Institute Australia, The University of SydneyVerified email at sydney.edu.au
Alexander J. Lazar MD/PhDProfessor; Pathology, Genomic Medicine, Dermatology & Transl Molec Pathol, MD Anderson Cancer CtrVerified email at mdanderson.org
Carlino Matteo SMelanoma Institute Australia; Westmead HospitalVerified email at sydney.edu.au
Jennifer Leigh McQuadeInstructor of Melanoma Medical Oncology, UT MD Anderson Cancer CenterVerified email at mdanderson.org
Rajmohan MuraliMemorial Sloan Kettering Cancer CenterVerified email at mskcc.org
Serigne LoMelanoma Institute Australia, The University of SydneyVerified email at melanoma.org.au
Peter HerseyVerified email at sydney.edu.au
Helen RizosMacquarie UniversityVerified email at mq.edu.au
Patrick HwuPresident and CEO, The Moffitt Cancer Center, Tampa, FLVerified email at moffitt.org

Lauren E. Haydu, PhD MPH

Mayo Clinic

Verified email at mayo.edu

Biostatistician


Title Sort by citations Sort by year Sort by title	Cited by Cited by	Year
Initial sequencing and analysis of the human genome US DOE Joint Genome Institute: Hawkins Trevor 4 Branscomb Elbert 4 Predki ... Nature 409 (6822), 860-921, 2001	25132	2001
Finishing the euchromatic sequence of the human genome International Human Genome Sequencing Consortium Nature 431 (7011), 931-945, 2004	5346	2004
The immune landscape of cancer V Thorsson, DL Gibbs, SD Brown, D Wolf, DS Bortone, THO Yang, ... Immunity 48 (4), 812-830. e14, 2018	4854	2018
Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients V Gopalakrishnan, CN Spencer, L Nezi, A Reuben, MC Andrews, ... Science 359 (6371), 97-103, 2018	4241	2018
An integrated TCGA pan-cancer clinical data resource to drive high-quality survival outcome analytics J Liu, T Lichtenberg, KA Hoadley, LM Poisson, AJ Lazar, AD Cherniack, ... Cell 173 (2), 400-416. e11, 2018	2932	2018
Genomic classification of cutaneous melanoma R Akbani, KC Akdemir, B áArman Aksoy, M Albert, A Ally, SB Amin, ... Cell 161 (7), 1681-1696, 2015	2831	2015
Oncogenic signaling pathways in the cancer genome atlas F Sanchez-Vega, M Mina, J Armenia, WK Chatila, A Luna, KC La, ... Cell 173 (2), 321-337. e10, 2018	2734	2018
Melanoma staging: evidence‐based changes in the American Joint Committee on Cancer eighth edition cancer staging manual JE Gershenwald, RA Scolyer, KR Hess, VK Sondak, GV Long, MI Ross, ... CA: a cancer journal for clinicians 67 (6), 472-492, 2017	2394	2017
Comprehensive characterization of cancer driver genes and mutations MH Bailey, C Tokheim, E Porta-Pardo, S Sengupta, D Bertrand, ... Cell 173 (2), 371-385. e18, 2018	2345	2018
Cell-of-origin patterns dominate the molecular classification of 10,000 tumors from 33 types of cancer KA Hoadley, C Yau, T Hinoue, DM Wolf, AJ Lazar, E Drill, R Shen, ... Cell 173 (2), 291-304. e6, 2018	2195	2018
B cells and tertiary lymphoid structures promote immunotherapy response BA Helmink, SM Reddy, J Gao, S Zhang, R Basar, R Thakur, K Yizhak, ... Nature 577 (7791), 549-555, 2020	1966	2020
Machine learning identifies stemness features associated with oncogenic dedifferentiation TM Malta, A Sokolov, AJ Gentles, T Burzykowski, L Poisson, JN Weinstein, ... Cell 173 (2), 338-354. e15, 2018	1780	2018
Prognostic and Clinicopathologic Associations of Oncogenic BRAF in Metastatic Melanoma GV Long, AM Menzies, AM Nagrial, LE Haydu, AL Hamilton, GJ Mann, ... Journal of Clinical Oncology 29 (10), 1239-1246, 2011	1311	2011
Analysis of immune signatures in longitudinal tumor samples yields insight into biomarkers of response and mechanisms of resistance to immune checkpoint blockade PL Chen, W Roh, A Reuben, ZA Cooper, CN Spencer, PA Prieto, JP Miller, ... Cancer discovery 6 (8), 827-837, 2016	979	2016
The cancer genome atlas comprehensive molecular characterization of renal cell carcinoma CJ Ricketts, AA De Cubas, H Fan, CC Smith, M Lang, E Reznik, R Bowlby, ... Cell reports 23 (1), 313-326. e5, 2018	899	2018
Comprehensive analysis of alternative splicing across tumors from 8,705 patients A Kahles, KV Lehmann, NC Toussaint, M Hüser, SG Stark, ... Cancer cell 34 (2), 211-224. e6, 2018	802	2018
Pathogenic germline variants in 10,389 adult cancers K Huang, RJ Mashl, Y Wu, DI Ritter, J Wang, C Oh, M Paczkowska, ... Cell 173 (2), 355-370. e14, 2018	772	2018
Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma RN Amaria, SM Reddy, HA Tawbi, MA Davies, MI Ross, IC Glitza, ... Nature medicine 24 (11), 1649-1654, 2018	764	2018
Scalable open science approach for mutation calling of tumor exomes using multiple genomic pipelines K Ellrott, MH Bailey, G Saksena, KR Covington, C Kandoth, C Stewart, ... Cell systems 6 (3), 271-281. e7, 2018	693	2018
Recurrent mutations in epigenetic regulators, RHOA and FYN kinase in peripheral T cell lymphomas T Palomero, L Couronné, H Khiabanian, MY Kim, A Ambesi-Impiombato, ... Nature genetics 46 (2), 166-170, 2014	690	2014

The system can't perform the operation now. Try again later.

Articles 1–20

Citations per year

Duplicate citations

Merged citations

Add co-authorsCo-authors

Follow

Cited by

Co-authors